新西兰对近4 000名婴儿进行的一项研究发现,早期使用parecetamol或ibuprofen与肝炎、哮喘或支气管炎之间没有任何联系。 A New Zealand study of nearly 4,000 infants finds no link between early paracetamol or ibuprofen use and eczema, asthma, or bronchiolitis.

新西兰对近4 000名婴儿进行的一项大型研究发现,头一年使用parepetamol或ibuprofen与肝炎、哮喘或支气管炎之间没有重要联系。 A large New Zealand study of nearly 4,000 infants finds no significant link between paracetamol or ibuprofen use in the first year and eczema, asthma, or bronchiolitis. 随机试验是PIPPATamariki研究的一部分,发现这两种药物组的情况相似,没有严重副作用。 The randomized trial, part of the PIPPATamariki study, found similar rates of these conditions in both medication groups and no serious side effects. 研究人员说,结果支持目前的指导方针,并向父母提供保障。 Researchers say the results support current guidelines and provide reassurance to parents. 这项研究由奥克兰大学科学家领导,由Cure Children和健康研究理事会资助,将继续跟踪六岁儿童,以评估哮喘和发育状况等长期风险。 The study, led by University of Auckland scientists and funded by Cure Kids and the Health Research Council, will continue tracking children through age six to assess long-term risks like asthma and developmental conditions.